Merck Aktie

87,30 EUR -1,40 EUR -1,58 %

21:30:46

STU

92,97 USD -0,21 USD -0,23 %

21:31:15

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.223,65 Mrd. EUR

KGV14,77Div. Rendite3,14%

WKNA0YD8Q

ISINUS58933Y1055

SymbolMRK

Merck Aktien News

Sortieren:Datum Meistgelesen

20:01BenzingaSpotlight on Merck & Co: Analyzing the Surge in Options Activity

03.03.25PR NewswireMRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit

03.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK

WerbungMerck-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

03.03.25PR NewswireMRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm

28.02.25ZacksMerck (MRK) Exceeds Market Returns: Some Facts to Consider

28.02.25ZacksMerck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?

28.02.25PR NewswireMRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

27.02.25BenzingaDecoding Merck & Co's Options Activity: What's the Big Picture?

25.02.25ZacksWall Street Analysts See Merck (MRK) as a Buy: Should You Invest?

25.02.25PR NewswireClass Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky

24.02.25ZacksThe Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis

22.02.25MotleyFoolIs Merck Stock a Buy?

21.02.25ZacksWhy Merck (MRK) is a Great Dividend Stock Right Now

20.02.25Korea TimesMerck highlights materials solutions for new chip architectures at SEMICON Korea

18.02.25BenzingaLooking Into Merck & Co's Recent Short Interest

18.02.25BenzingaBeyond The Numbers: 13 Analysts Discuss Merck & Co Stock

16.02.25PR NewswireMRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

13.02.25BenzingaDecoding Merck & Co's Options Activity: What's the Big Picture?

13.02.25ZacksMerck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

12.02.25Financial TimesChina leaves Merck in need of a new profit injection

11.02.25BenzingaGermany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics

11.02.25BenzingaRecent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock

11.02.25PR NewswireHealth Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination w...

10.02.25MotleyFoolBetter High-Yield Dividend Stock: Pfizer vs. Merck

05.02.25BenzingaAnalysts Defend Merck Amid Investor Concerns Over Weak Guidance

05.02.25ZacksWhy Merck (MRK) is a Top Dividend Stock for Your Portfolio

04.02.25MotleyFoolMerck (MRK) Q4 2024 Earnings Call Transcript

04.02.25MotleyFoolWhy Merck Stock Is Plummeting Today

04.02.25ZacksMerck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 View

04.02.25ZacksMerck (MRK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

04.02.25Financial TimesMerck shares sink 11% after vaccine shipments to China halted

04.02.25ZacksMerck (MRK) Tops Q4 Earnings and Revenue Estimates

04.02.25PR NewswireCIBC introduces additional Canadian Depositary Receipts ("CDRs")

04.02.25ZacksThe Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb

03.02.25BenzingaMerck Vs. Pfizer: Which Pharmaceutical Giant Will Prevail In Q4 Earnings?

31.01.25ZacksMerck (MRK) Stock Moves -0.13%: What You Should Know

31.01.25ZacksMerck Halts Second PAH Drug Study Early on Strong Efficacy Results

31.01.25ZacksUnveiling Merck (MRK) Q4 Outlook: Wall Street Estimates for Key Metrics

30.01.25ZacksMerck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Merck News

Merck News: auf dieser Seite finden Sie alle Merck News und Nachrichten zur Merck Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Merck News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Merck News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.